Neutralization of Human Papillomavirus Type 11 (HPV-11) by Serum from Women Vaccinated with Yeast-Derived HPV-11 L1 Virus-like Particles: Correlation with Competitive Radioimmunoassay Titer
Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like particles (VLPs). Theoretically, neutralizing antibodies could protect women from HPV infection. The immunogenicity of a yeast-derived HPV-11 L1...
Saved in:
| Published in | The Journal of infectious diseases Vol. 184; no. 9; pp. 1183 - 1186 |
|---|---|
| Main Authors | , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Chicago, IL
The University of Chicago Press
01.11.2001
University of Chicago Press |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like particles (VLPs). Theoretically, neutralizing antibodies could protect women from HPV infection. The immunogenicity of a yeast-derived HPV-11 L1 VLP vaccine was tested in women. Serum specimens were evaluated for HPV-11 titer by competitive radioimmunoassay (cRIA) and for neutralization by use of the athymic mouse xenograft system. Analysis of serum from 104 subjects showed a dose response in HPV-11 cRIA titers and neutralization. Overall, 68 (82.9%) of 82 postimmunization serum specimens from VLP recipients were 100% neutralizing when used in the assay at a 1:50 dilution. Of 69 serum specimens, 63 (91.3%) with cRIA titers >200 milliMerck units per milliliter were neutralizing. Immunization with HPV VLPs elicits a vigorous serum immune response in a high percentage of women. The HPV-11 cRIA titer appears to be a surrogate marker for neutralization |
|---|---|
| AbstractList | Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like particles (VLPs). Theoretically, neutralizing antibodies could protect women from HPV infection. The immunogenicity of a yeast-derived HPV-11 L1 VLP vaccine was tested in women. Serum specimens were evaluated for HPV-11 titer by competitive radioimmunoassay (cRIA) and for neutralization by use of the athymic mouse xenograft system. Analysis of serum from 104 subjects showed a dose response in HPV-11 cRIA titers and neutralization. Overall, 68 (82.9%) of 82 postimmunization serum specimens from VLP recipients were 100% neutralizing when used in the assay at a 1:50 dilution. Of 69 serum specimens, 63 (91.3%) with cRIA titers >200 milliMerck units per milliliter were neutralizing. Immunization with HPV VLPs elicits a vigorous serum immune response in a high percentage of women. The HPV-11 cRIA titer appears to be a surrogate marker for neutralization Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like particles (VLPs). Theoretically, neutralizing antibodies could protect women from HPV infection. The immunogenicity of a yeast-derived HPV-11 L1 VLP vaccine was tested in women. Serum specimens were evaluated for HPV-11 titer by competitive radioimmunoassay (cRIA) and for neutralization by use of the athymic mouse xenograft system. Analysis of serum from 104 subjects showed a dose response in HPV-11 cRIA titers and neutralization. Overall, 68 (82.9%) of 82 postimmunization serum specimens from VLP recipients were 100% neutralizing when used in the assay at a 1: 50 dilution. Of 69 serum specimens, 63 (91.3%) with cRIA titers >200 milliMerck units per milliliter were neutralizing. Immunization with HPV VLPs elicits a vigorous serum immune response in a high percentage of women. The HPV-11 cRIA titer appears to be a surrogate marker for neutralization. Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like particles (VLPs). Theoretically, neutralizing antibodies could protect women from HPV infection. The immunogenicity of a yeast-derived HPV-11 L1 VLP vaccine was tested in women. Serum specimens were evaluated for HPV-11 titer by competitive radioimmunoassay (cRIA) and for neutralization by use of the athymic mouse xenograft system. Analysis of serum from 104 subjects showed a dose response in HPV-11 cRIA titers and neutralization. Overall, 68 (82.9%) of 82 postimmunization serum specimens from VLP recipients were 100% neutralizing when used in the assay at a 1:50 dilution. Of 69 serum specimens, 63 (91.3%) with cRIA titers >200 milliMerck units per milliliter were neutralizing. Immunization with HPV VLPs elicits a vigorous serum immune response in a high percentage of women. The HPV-11 cRIA titer appears to be a surrogate marker for neutralization. |
| Author | Barr, Eliav Jansen, Kathrin U. Fife, Kenneth H. Brown, Darron R. Schroeder, Jill M. Chiacchierini, Lisa Robinson, Tiffany S. Bryan, Janine T. DiCello, Anthony Smith, Paula R. Wheeler, Cosette M. |
| Author_xml | – sequence: 1 givenname: Darron R. surname: Brown fullname: Brown, Darron R. organization: Indiana University School of Medicine and – sequence: 2 givenname: Janine T. surname: Bryan fullname: Bryan, Janine T. organization: Merck Research Laboratories, West Point, Pennsylvania – sequence: 3 givenname: Jill M. surname: Schroeder fullname: Schroeder, Jill M. organization: Indiana University School of Medicine and – sequence: 4 givenname: Tiffany S. surname: Robinson fullname: Robinson, Tiffany S. organization: Indiana University School of Medicine and – sequence: 5 givenname: Kenneth H. surname: Fife fullname: Fife, Kenneth H. organization: Indiana University School of Medicine and – sequence: 6 givenname: Cosette M. surname: Wheeler fullname: Wheeler, Cosette M. organization: University of New Mexico Health Sciences Center, Albuquerque – sequence: 7 givenname: Eliav surname: Barr fullname: Barr, Eliav organization: Merck Research Laboratories, West Point, Pennsylvania – sequence: 8 givenname: Paula R. surname: Smith fullname: Smith, Paula R. organization: Merck Research Laboratories, West Point, Pennsylvania – sequence: 9 givenname: Lisa surname: Chiacchierini fullname: Chiacchierini, Lisa organization: Merck Research Laboratories, West Point, Pennsylvania – sequence: 10 givenname: Anthony surname: DiCello fullname: DiCello, Anthony organization: Merck Research Laboratories, West Point, Pennsylvania – sequence: 11 givenname: Kathrin U. surname: Jansen fullname: Jansen, Kathrin U. organization: Merck Research Laboratories, West Point, Pennsylvania |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14156779$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/11598842$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkc1u1DAUhS1URH-AR0BmAYJFIP6JPWGHpsAgRkNVhimwiW6SG2Eax8F2CsO78W5kyKhdIbG60tF3zrnSOSYHneuQkPssfcbSmXouuFAyu0WOWCZ0ohQTB-QoTTlP2CzPD8lxCN_SNJVC6TvkkLEsn80kPyK_VzhED635BdG4jrqGLgYLHT2D3rSts3Bl_BDoetsjZYw-WZxtEsae0nJLP6AfLG28s_TCWezoBqrKdBCxpj9M_Eo_I4SYnKI3V6M0OemS0c0uMmnNJY41PpqqxfCCzp332E5v_LXPne0xmji66TnUxhlrh85BCLClaxPR3yW3G2gD3tvfE_Lx9av1fJEs3795O3-5TCopeEzKMlO1FLqSZS50DVlZqaaBRkDOOJd8lCQDnUomaq5BMdRyxjOZpXkJqHJxQh5Pub133wcMsbAmVNi20KEbQqE5y3X-HyAbY0U-9lyDlXcheGyK3hsLfluwtNgtWkyLjuCDfeJQWqxvsP2EI_BoD0CooG08dJUJN5xkmdJ699rDiXND_--yZGJMiPjzmgJ_WSgtdFYsPn0psvX5anV6wYp34g8rd8OI |
| CODEN | JIDIAQ |
| CitedBy_id | crossref_primary_10_1038_ncponc0770 crossref_primary_10_1128_JVI_76_15_7832_7842_2002 crossref_primary_10_1586_14737140_5_1_97 crossref_primary_10_1111_IGC_0b013e3181a3d100 crossref_primary_10_2515_therapie_2005035 crossref_primary_10_1016_j_humpath_2004_04_007 crossref_primary_10_1038_nrmicro867 crossref_primary_10_1128_JVI_77_8_4635_4645_2003 crossref_primary_10_1345_aph_1G723 crossref_primary_10_1002_14651858_CD009069_pub3 crossref_primary_10_1002_14651858_CD009069_pub2 crossref_primary_10_1016_j_jcv_2004_12_008 crossref_primary_10_1016_S1473_3099_03_00720_5 crossref_primary_10_1016_S1773_035X_08_74280_1 crossref_primary_10_1097_QAI_0000000000001355 crossref_primary_10_1128_JCM_44_2_571_579_2006 crossref_primary_10_1146_annurev_med_55_091902_103520 crossref_primary_10_1517_14712598_5_9_1193 crossref_primary_10_1016_j_ymeth_2006_05_020 crossref_primary_10_1155_IDOG_2006_83084 crossref_primary_10_1186_1476_8518_3_2 crossref_primary_10_2217_fvl_14_44 crossref_primary_10_1016_S0042_6822_03_00196_X crossref_primary_10_1016_j_virol_2005_03_022 crossref_primary_10_1097_01_gco_0000216316_10690_c6 crossref_primary_10_1016_S1473_3099_05_70323_6 crossref_primary_10_1056_NEJMoa020586 crossref_primary_10_1016_j_vaccine_2003_11_059 crossref_primary_10_1128_CDLI_10_1_108_115_2003 crossref_primary_10_1016_j_vaccine_2005_09_001 crossref_primary_10_1016_j_vaccine_2006_04_068 crossref_primary_10_1097_IIO_0000000000000157 crossref_primary_10_1093_oxfordjournals_jncimonographs_a003487 crossref_primary_10_1128_JCM_40_5_1755_1760_2002 crossref_primary_10_1016_S0733_8635_02_00098_0 crossref_primary_10_1155_IDOG_2006_59089 crossref_primary_10_1016_j_lpm_2009_06_016 crossref_primary_10_1099_vir_0_18872_0 crossref_primary_10_1111_j_1479_828X_2006_00580_x crossref_primary_10_1016_S0755_4982_05_84030_8 crossref_primary_10_1093_femsyr_foz007 crossref_primary_10_1016_j_clinmicnews_2005_09_001 crossref_primary_10_1016_j_vaccine_2003_11_058 crossref_primary_10_1002_jmv_20245 crossref_primary_10_1016_j_vaccine_2004_02_020 crossref_primary_10_1016_j_vaccine_2004_07_046 crossref_primary_10_1007_s00105_007_1346_5 crossref_primary_10_1016_S1470_2045_05_70101_7 crossref_primary_10_2165_00024669_200302040_00004 crossref_primary_10_1586_erv_11_135 crossref_primary_10_1093_jnci_djg018 crossref_primary_10_1007_s00705_006_0798_8 crossref_primary_10_1016_j_revmed_2006_09_025 crossref_primary_10_1111_j_1365_2249_2010_04268_x |
| ContentType | Journal Article |
| Copyright | 2001 by the Infectious Diseases Society of America 2001 2002 INIST-CNRS |
| Copyright_xml | – notice: 2001 by the Infectious Diseases Society of America 2001 – notice: 2002 INIST-CNRS |
| DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U9 H94 7X8 |
| DOI | 10.1086/323645 |
| DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1537-6613 |
| EndPage | 1186 |
| ExternalDocumentID | 10_1086_323645 11598842 14156779 10.1086/323645 ark_67375_HXZ_5TRNNDW1_K |
| Genre | Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -DZ -~X ..I .2P .55 .GJ .I3 .XZ .ZR 08P 0R~ 123 1TH 29K 2AX 2WC 36B 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 70D 85S AABZA AACGO AACZT AAHBH AAHTB AAJKP AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWTL ABBHK ABEJV ABEUO ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPEJ ABPLY ABPPZ ABPTD ABQLI ABQNK ABTLG ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACGOD ACPRK ACUFI ACUTO ACYHN ADACV ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFNX AFFZL AFHKK AFIYH AFOFC AFXAL AFXEN AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AI. AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BR6 BSCLL BTRTY BVRKM C45 CDBKE CS3 CZ4 D-I DAKXR DCCCD DIK DILTD DOOOF DU5 D~K EBS ECGQY EE~ EJD EMOBN ENERS ESX F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HQ3 HTVGU HW0 HZ~ IH2 IOX IPSME J21 J5H JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JSODD JST KAQDR KBUDW KOP KQ8 KSI KSN L7B LSO LU7 M49 MHKGH MJL ML0 MVM N4W N9A NEJ NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TR2 VH1 W2D W8F WH7 X7H X7M Y6R YAYTL YKOAZ YXANX ZGI ZXP ~91 AASNB 08R 1KJ 41~ 6.Y 69O 8W4 AABJS AABMN AAESY AAIYJ AAJQQ AANRK AAPGJ AAWDT AAYOK ABFLS ABPTK ABSAR ABSMQ ACFRR ACIMA ACPQN ACUTJ ADEIU ADGIM ADMTO ADORX ADQLU ADZLD AEKPW AGKRT AGVJH AHGVY AIKOY AIMBJ AQDSO AQKUS ASMCH AWCFO AZQFJ BGYMP BYORX BZKNY DNJUQ DPORF DPPUQ DWIUU EIHJH G8K H13 IQODW MBLQV O~Y P0- PQEST TMA UMP ZA5 ZE2 ZKG CGR CUY CVF ECM EIF NPM AAYXX ABDPE ACMRT ACZBC AFSHK AFYAG AGMDO AHMMS APJGH AVNTJ CITATION 7U9 H94 7X8 |
| ID | FETCH-LOGICAL-c432t-bb56d437c4b937da5bc6ffaf3a9122427da41a70413d27a61e748254509bae693 |
| ISSN | 0022-1899 |
| IngestDate | Wed Dec 04 04:59:38 EST 2024 Wed Dec 04 16:09:46 EST 2024 Fri Dec 06 03:05:39 EST 2024 Tue Oct 15 23:23:11 EDT 2024 Thu Nov 24 18:22:06 EST 2022 Wed Sep 11 04:51:05 EDT 2024 Wed Oct 30 09:43:29 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | Human Yeast Antibody Secretion Use Vaccination Rodentia Vaccine Papovaviridae Female genital diseases Papillomavirus Virus Vertebrata Human papillomavirus Mammalia Immunogenicity Mouse Radioimmunoassay Primates Female Serum Cervicitis Uterine cervix diseases Neutralization |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c432t-bb56d437c4b937da5bc6ffaf3a9122427da41a70413d27a61e748254509bae693 |
| Notes | istex:3A0752C02C2BA6600F23A61904B21A2DF10EB823 ark:/67375/HXZ-5TRNNDW1-K ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-News-3 |
| OpenAccessLink | https://academic.oup.com/jid/article-pdf/184/9/1183/18004177/184-9-1183.pdf |
| PMID | 11598842 |
| PQID | 18253941 |
| PQPubID | 23462 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_72197969 proquest_miscellaneous_18253941 crossref_primary_10_1086_323645 pubmed_primary_11598842 pascalfrancis_primary_14156779 oup_primary_10_1086_323645 istex_primary_ark_67375_HXZ_5TRNNDW1_K |
| PublicationCentury | 2000 |
| PublicationDate | 2001-11-01 |
| PublicationDateYYYYMMDD | 2001-11-01 |
| PublicationDate_xml | – month: 11 year: 2001 text: 2001-11-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Chicago, IL |
| PublicationPlace_xml | – name: Chicago, IL – name: United States |
| PublicationTitle | The Journal of infectious diseases |
| PublicationTitleAbbrev | The Journal of Infectious Diseases |
| PublicationTitleAlternate | The Journal of Infectious Diseases |
| PublicationYear | 2001 |
| Publisher | The University of Chicago Press University of Chicago Press |
| Publisher_xml | – name: The University of Chicago Press – name: University of Chicago Press |
| SSID | ssj0004367 |
| Score | 2.0518837 |
| Snippet | Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervical secretions from primates vaccinated with virus-like... |
| SourceID | proquest crossref pubmed pascalfrancis oup istex |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1183 |
| SubjectTerms | Adolescent Adult Animals Antibodies, Viral - blood Antibodies, Viral - immunology Biological and medical sciences Dose-Response Relationship, Drug Double-Blind Method Female Human papillomavirus 11 Human viral diseases Humans Infectious diseases Medical sciences Mice Neutralization Tests Papillomaviridae - genetics Papillomaviridae - immunology Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Radioimmunoassay Tumor Virus Infections - prevention & control Tumor Virus Infections - virology Vaccination Vaccines, Synthetic - immunology Viral diseases Viral diseases of the genital and urinary system Viral diseases of the lymphoid tissue and the blood. Aids Viral Vaccines - immunology Virion - immunology Yeasts - genetics |
| Title | Neutralization of Human Papillomavirus Type 11 (HPV-11) by Serum from Women Vaccinated with Yeast-Derived HPV-11 L1 Virus-like Particles: Correlation with Competitive Radioimmunoassay Titer |
| URI | https://api.istex.fr/ark:/67375/HXZ-5TRNNDW1-K/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/11598842 https://search.proquest.com/docview/18253941 https://search.proquest.com/docview/72197969 |
| Volume | 184 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJhASQjC-OmD4ASFQFVQ3jp3wBvtQ6boyjW4UXiI7TUVZ11RdO9H9Xzzyv3FnJ3WKNvHxErVuco11P9t359_5CHkeKlHjUgov0CIEB0VrL-rLyPMDqWtM40YVJjjvt0XjiDe7QXdl5UeJtTSb6tfJxaV5Jf-jVWgDvWKW7D9odiEUGuAz6BeuoGG4_pWO2-nMBCouFnafjckfqPFgOMxO1flgMjuroq9ZZQyNycbBsYeTV4RmJ8wTs1ObYGIKWVaPVZIMRmpaUNI_Y2Efbxu6cg5N9tlqi1WPUaw3HJyk8FclZt0Wlvqw5DorYMtY5ZaedKh6g2yA6SgZGOwm-6SgBn9zkG2WT7KwPDHoQb6N5EL6RfDAbVS9m8xtLLfpeN8fk6-TLO1ZVDZd4Lec9NbJg79F5IPlKYCl2RwcaRbaAktuNucl2EaluRlcKb-0zsNXcekaUjNbWj6erB-4VbJgBrQ_xLtHrVbc2el2rpE1PH8RSzZsv99z6bi-kMUh9fh6pZJWVuqSDbSGw_l7kV95a6zOYHD2bVWVq90eY_507pDbuVroW6vtu2QlHa2T67aS6Xyd3NjPORr3yM9lVNKsTw0q6TIqKaKSMkZfWly9onpODSIpIpIaRFKHSIqAokuIpPZJ2mLUIZIuEPmGlvBoHy_hkf6OR2rweJ8c7e50thpeXiTES7hfn3paB6LHfZlwDZZ2TwU6Ef2-6vsqwk3jOjRxpmQNjLVeXSrBUskxKgKGslapiPwHZHWUjdJHhIZcI4cqSkI_5LVUgyUb8iRJBUIlSP0KeVaoLR7bs2Biw-EIRWwVWyEvjDYXP6vJCTInZRA3ul_ioHPYbm9_YvFehWyAuq-UsrmEAncbRlukjOBFCljEsBrgFp8apTAcYwZd8yPOrr5DgokiIwEyHlo8Oeng2YQhr2_8UfpjctONxydkdTqZpU_BNp_qTTMSfgEWtuXS |
| link.rule.ids | 314,780,784,27924,27925 |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutralization+of+Human+Papillomavirus+Type+11+%28HPV-11%29+by+Serum+from+Women+Vaccinated+with+Yeast-Derived+HPV-11+L1+Virus-like+Particles%3A+Correlation+with+Competitive+Radioimmunoassay+Titer&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Brown%2C+DR&rft.au=Bryan%2C+J+T&rft.au=Schroeder%2C+J+M&rft.au=Robinson%2C+T+S&rft.date=2001-11-01&rft.issn=0022-1899&rft.volume=184&rft.issue=9&rft.spage=1183&rft.epage=1186&rft_id=info:doi/10.1086%2F323645&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon |